Science 37 (SNCE) was a key enrolling site for the primary completion of a Phase 3 rare disease trial sponsored by global biopharmaceutical company, GSK (GSK). The hepatology study of an ...

Science 37 received an economic incentive to create 250 jobs at its new RTP headquarters. Its plans didn’t work out.

The Belgium biopharma company is collaborating with California’s Science 37, which says its ‘decentralised’ clinical research model offers greater patient value and results in data that is ...

The Swiss pharma company is to begin up to 10 new trials with Science 37, which is pioneering a ‘site-less’ trial model, over the next three years. Novartis was an early investor in LA-based ...

State officials approved requests from Science 37 and MasterBrand to cancel grants worth up to a combined $7.1 million. The projects were initially expected to create more than 700 jobs combined, ...

U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing ...

Science 37, Inc. MORRISVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, was a key enrolling site for the primary completion of a ...